Back to search

Article

Biglycan Overexpression Predicts Poor Prognosis of Gastric Cancer

2021-05-04

Abstract excerpt

<h4>Background: </h4> Biglycan (BGN) encodes an extracellular matrix (ECM) proteoglycan. However, the potential diagnostic and prognostic value of BGN in gastric cancer (GC) have not yet been reported. In this analysis, BGN expression in GC was evaluated across the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and Oncomine databases, and verified using immunohistochemistry (IHC). The relationship...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a9e60c7b-06da-5a18-b649-633502dd76e3
DOI
10.21203/rs.3.rs-419860/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biglycan Overexpression Predicts Poor Prognosis of Gastric CancerDOI 10.21203/rs.3.rs-419860/v1
Select a neighboring publication to make it the new centre.